Dental Anxiety
Conditions
Interventions
This is a triple-blind randomized clinical trial with a placebo group. 44 individuals will be selected who will undergo surgery for third molar extraction included in the Teaching Dental Clinic (COE)
Annex A
DANIEL et al., 1995
SILVA and CORREIA, 1997) before and after the dental treatment session. of the ILIB/placebo. The vital signs of the research participants will be evaluated in two moments: before the application of th
and after 4 minutes of local anesthesia. Patients in group 1 (n=22), control group, will undergo placebo treatment with ILIB. Low power laser equipment (InGaAlP) will be used, coupled to a bracelet (L
E02.594
Sponsors
Universidade Evangélica de Goiás
Universidade Evangélica de Goiás
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients who agree to participate in the study and sign the free and informed consent form; older than 18 years; both genders; ASA classification I or II (American Society of Anesthesiologists, 2023), who have not previously undergone third molar extraction; indication of extraction of at least one lower third molar, with a moderate or minimally difficult level according to Pederson's classification
Exclusion criteria
Exclusion criteria: Patients with signs of infection or inflammation in the tissues adjacent to the teeth indicated for extraction; with psychiatric disorders; cognitive distortions that interfere with the application of the questionnaire; patients using anxiolytics or antidepressants; pregnant women; patients who do not have at least one radial artery available for Intravascular Laser Blood Irradiation (ILIB) therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate the level of anxiety through the score obtained in the STAI-Y questionnaire before and after the laser therapy session (or placebo). A greater reduction in scores is expected in the intervention group | — |
Secondary
| Measure | Time frame |
|---|---|
| Vital signs (diastolic and systolic blood pressure, heart rate and oxygen saturation) will be measured using a digital sphygmomanometer and pulse oximeter, before and after the intervention/placebo. The intervention group is expected to show a more significant reduction in blood pressure and heart rate, but improvement or maintenance of oxygen saturation;Evaluate the cortisol concentration in the patients' saliva, before the intervention/placebo and after. A reduction in salivary cortisol concentration levels is expected in patients undergoing the intervention | — |
Countries
Brazil
Contacts
Public ContactAllisson Martins
Universidade Evangélica de Goiás
Outcome results
None listed